Jobbeschreibung
With over 120 years of experience and more than 17,000 employees in over 20 countries, Daiichi Sankyo is dedicated to discovering, developing, and delivering new standards of care that enrich the quality of life around the world.
In Europe, we focus on two areas: The goal of our Specialty Business is to protect people from cardiovascular disease, the leading cause of death in Europe, and help patients who suffer from it to enjoy every precious moment of life. In Oncology, we strive to become a global pharma innovator with competitive advantage, creating novel therapies for people with cancer.
Our European headquarters are in Munich, Germany, and we have affiliates in 13 European countries and Canada.
We are seeking highly qualified candidates to fill the position:
Director Global Oncology Pricing, Reimbursement & Access (m/f/x)
The Position:
The Director, Global Oncology Pricing & Access will both develop and execute the market access and pricing strategies for the oncology asset. This person will own the pricing and access strategy for current oncology assets as assigned. This person will report to the Sr Director, Global Pricing & Access, and will be responsible for providing strategic and technical expertise to drive the success of the asset.
The individual will lead global pricing strategy development, access strategy development and partner with stakeholders in the development of innovative access solutions. The role involves establishing strong working relationships with the Regional and Local Access leads; alliance partners; and strong collaborations with global functions including but not limited to Commercial, Marketing, Medical, & Clinical Development.
- Global Market Access & Strategy
- Lead the development of pricing, reimbursement and access strategies working cross-functionally/regionally
- Develop initial price assumptions and reimbursement & access strategy recommendations
- Draft and establish price guidance in collaboration with top countries and regions, including design of a global launch sequence plan by collaborating cross-functionally
- Provide pricing input to key planning processes for Brand planning and portfolio review
- Provides input to Clinical on trial design, endpoints and comparators to support optimal price, access and reimbursement
- Enhance information exchange and best practice sharing across regions; drive adoption of pricing tools and resources
- Ensure pricing inputs & assumptions are incorporated into the forecasting and strategic planning process
- Monitor fast-changing competitive landscape and ensure insights factored in the PRA strategy
- Evidence Generation & Synthesis
- Collaborate cross-functionally to gather overview information of target indications including epidemiology, disease burden, unmet needs, cost of illness, and treatment patterns/pathways
- Provide and maintain an in-depth understanding of changing pricing, reimbursement & access environment, processes, and policies of key global markets
- Conduct pricing &payer market research in collaboration with key markets/regions
- Stakeholder Engagement
- Partner with Regional and Global stakeholders to provide innovative PRA approaches
- Collaborate with Clinical (R&D) to ensure that Payer and KOL reimbursement requirements for key markets are included in the clinical trial / evidence generation plans
- Act as an ambassador to drive the access agenda with key stakeholders
- Master's Degree in economics, health policy, health economics, pharmaceutical sciences, medicines, or other relevant qualification
- 10 or More Years overall related experience, 7 or More Years of progressive relevant experience acquired at pharmaceutical companies, Payer/HTA, physician associations or relevant consultancy companies in a multi-national context
- 4 or More Years demonstrated experience with developing global pricing, reimbursement and access strategies
- Having worked in oncology, preferably with multi-indication compounds as well as with early-stage compounds
- Excellent understanding of the clinical development and life cycle of oncology medicines
- Strong knowledge of major markets and their PRA and HTA policies: US and Global, both private and government setting
- Experience in collaboration with early assets teams, clinical development and forecasting teams
- Knowledge of pricing and reimbursement schemes in different areas of the world
- Excellent knowledge of pricing market research tools, methodologies, and analytics
- Good understanding of HEOR and RWE concepts
- Excellent Benefits
- Work-Life-Balance
- Growth and Development
- Health and Wellbeing Support